InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,141.20
(
0.63%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
80.92
(
0.14%
)
Bitcoin
69,138.05
(
2.05%
)

Replies to post #15368 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #15368 on Momenta Pharmaceuticals, Inc. (MNTA)

Betchips

02/19/16 11:13 AM

#15370 RE: pollyvonwog #15368

Looks like a setup back to $10 today

IanFromSI

02/19/16 8:44 PM

#15382 RE: pollyvonwog #15368

Roche will probably get approval prior to year end 2016. I suspect that Ocrel... will eat into Glatopa and all other existing tx sales fairly quickly.

REF: Roche Hldg receives Breakthrough Therapy Designation from FDA for Ocrelizumab (RHHBY) :

DewDiligence

02/20/16 11:49 AM

#15388 RE: pollyvonwog #15368

MNTA's 12/31/15 pro forma cash balance=$416M: #msg-120660991.